Longevity Today
Academic PapersReviewsVideosPodcastsPress ReleasesClinical TrialsDrug ApprovalsTutorialsAnimations
All Articles
Sign In
Deep Dive Audio
SystemAge 2.1 Brings Sex-Specific Biological Age Testing Across 21 Organ SystemsLongevity & Aging

SystemAge 2.1 Brings Sex-Specific Biological Age Testing Across 21 Organ Systems

Generation Lab has released SystemAge 2.1, a biological age test that now offers dedicated male and female versions, measuring over 460 biomarkers across 21 organ systems from a single needle-free blood draw. New additions include coverage of skin, connective tissue, reproductive health, and mitochondrial function. The platform uses a metric called Biological Noise — based on DNA methylation variability — which the company says outperforms established clocks like DunedinPACE and PhenoAge. It also tracks how specific interventions such as NAD+, peptides, stem cells, and therapeutic plasma exchange affect biological age over time. The test is already deployed across 750+ clinics in 18 countries, with reported average biological age reductions of 5.5 years from stem cell protocols.

0:00--:--
Read Full Article
Longevity Today

Developed by the Clinical and Foundational Medicine Institute

AI-powered summaries of the world's best longevity research — from peer-reviewed journals to expert podcasts and YouTube deep-dives. Built for those who take their healthspan seriously.

info@LongevityToday.com

Categories

CancerHeart DiseaseAlzheimer'sParkinson'sDiabetesGut HealthNutritionStrength & FitnessSupplements & PeptidesStem CellsReversing AgingAuto-ImmunityAdvanced Therapies

Platform

  • All Articles
  • Membership Plans
  • Search
  • Newsletter

Newsletter

Weekly longevity research, summarized.

Enter your email to subscribe:

© 2026 Longevity Today. All rights reserved.

About UsPrivacy PolicyTerms of UseMedical Disclaimer

Content on Longevity Today is for informational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before making health decisions.